MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

• Published in: Cancer research (Chicago, Ill.) Ill.), 2010-10, Vol.70 (19), p.7379-7391
• Main Authors: BORRAS, Ester, PINEDA, Marta, BALMANA, Judith, TORRES, Asunción, RAMON Y CAJAL, Teresa, SANZ, Judit, PEREZ-CABORNERO, Lucia, CASTELLVI-BEL, Sergi, ALONSO, Angel, LANAS, Angel, GONZALEZ, Sara, MORENO, Victor, BLANCO, Ignacio, GRUBER, Stephen B, ROSENBERG, Noah A, MUKHERJEE, Bhramar, LAZARO, Conxi, CAPELLA, Gabriel, JEWETT, Ethan M, FEI WANG, TEULE, Alex, CALDES, Trinidad, URIOSTE, Miguel, MARTINEZ-BOUZAS, Cristina, BRUNET, Joan
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing - genetics; Adult; Age Factors; Aged; Antineoplastic agents; Base Sequence; Biological and medical sciences; Colorectal Neoplasms, Hereditary Nonpolyposis - epidemiology; Colorectal Neoplasms, Hereditary Nonpolyposis - genetics; Colorectal Neoplasms, Hereditary Nonpolyposis - pathology; Family Health; Female; Gastroenterology. Liver. Pancreas. Abdomen; Genetic Predisposition to Disease; Germ-Line Mutation; Haplotypes; HCT116 Cells; Humans; Male; Medical sciences; Middle Aged; Molecular Sequence Data; MutL Protein Homolog 1; Nuclear Proteins - genetics; Penetrance; Pharmacology. Drug treatments; Spain - epidemiology; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumors; Young Adult
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.CAN-10-0570

The variants c.306+5G>A and c.1865T>A (p.Leu622His) of the DNA repair gene MLH1 occur frequently in Spanish Lynch syndrome families. To understand their ancestral history and clinical effect, we performed functional assays and a penetrance analysis and studied their genetic and geographic origins. Detailed family histories were taken from 29 carrier families. Functional analysis included in silico and in vitro assays at the RNA and protein levels. Penetrance was calculated using a modified segregation analysis adjusted for ascertainment. Founder effects were evaluated by haplotype analysis. The identified MLH1 c.306+5G>A and c.1865T>A (p.Leu622His) variants are absent in control populations and segregate with the disease. Tumors from carriers of both variants show microsatellite instability and loss of expression of the MLH1 protein. The c.306+5G>A variant is a pathogenic mutation affecting mRNA processing. The c.1865T>A (p.Leu622His) variant causes defects in MLH1 expression and stability. For both mutations, the estimated penetrance is moderate (age-cumulative colorectal cancer risk by age 70 of 20.1% and 14.1% for c.306+5G>A and of 6.8% and 7.3% for c.1865T>A in men and women carriers, respectively) in the lower range of variability estimated for other pathogenic Spanish MLH1 mutations. A common haplotype was associated with each of the identified mutations, confirming their founder origin. The ages of c.306+5G>A and c.1865T>A mutations were estimated to be 53 to 122 and 12 to 22 generations, respectively. Our results confirm the pathogenicity, moderate penetrance, and founder origin of the MLH1 c.306+5G>A and c.1865T>A mutations. These findings have important implications for genetic counseling and molecular diagnosis of Lynch syndrome.